Increased Risk of Myocardial Infarction Among Patients With Type 2 Diabetes Who Carry the Common rs10830963 Variant in the <i>MTNR1B</i> Gene.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32616615.
- Also identified by DOI 10.2337/dc20-0507 and PMC identifier 7440907.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The common <i>MTNR1B</i> single nucleotide polymorphism rs10830963 associates with risk of type 2 diabetes (T2D). Here, we examine the association between this gene variant and the risk of myocardial infarction (MCI) among patients with T2D. MCI is a main cause of death and disability among such individuals. Data from the UK Biobank cohort were used in order to examine the association between rs10830963 and incidence of MCI (fatal and nonfatal) among 13,655 participants with probable T2D during a follow-up period of 6.8 years. Assuming an additive genetic model, a positive association was found between the rs10830963 variant in the <i>MTNR1B</i> gene and the risk for incident MCI during the 6.8-year follow-up (adjusted hazard ratio per G allele 1.19 [95% CI 1.02, 1.40], <i>P</i> = 0.03). The rs10830963 polymorphism may be a useful genetic marker for MCI in patients with T2D.
Medical subject headings
- Diabetes Mellitus, Type 2
- Myocardial Infarction
- Receptor, Melatonin, MT2